| 2F0 | 表記: | 2-chloro-5-{[(2-{3-[(1E)-N-hydroxyethanimidoyl]phenyl}propan-2-yl)carbamoyl]amino}benzamide | 組成式: | C19 H21 Cl N4 O3 | SMILES: | O=C(c1cc(ccc1Cl)NC(=O)NC(c2cccc(C(=NO)C)c2)(C)C)N | InChi: | InChI=1S/C19H21ClN4O3/c1-11(24-27)12-5-4-6-13(9-12)19(2,3)23-18(26)22-14-7-8-16(20)15(10-14)17(21)25/h4-10,27H,1-3H3,(H2,21,25)(H2,22,23,26)/b24-11+ | 別名: | P32 | 定義日: | 2013-10-03 | 最終更新日: | 2021-03-01 | 公開日: | 2014-07-23 | 識別子(ID): | 2-chloro-5-{[(2-{3-[(1E)-N-hydroxyethanimidoyl]phenyl}propan-2-yl)carbamoyl]amino}benzamide |
|
| 8PE | 表記: | (2R)-3-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-(tetradecanoyloxy)propyl octadecanoate | 組成式: | C37 H74 N O8 P | SMILES: | O=C(OCC(OC(=O)CCCCCCCCCCCCC)COP(=O)(OCCN)O)CCCCCCCCCCCCCCCCC | InChi: | InChI=1S/C37H74NO8P/c1-3-5-7-9-11-13-15-16-17-18-20-21-23-25-27-29-36(39)43-33-35(34-45-47(41,42)44-32-31-38)46-37(40)30-28-26-24-22-19-14-12-10-8-6-4-2/h35H,3-34,38H2,1-2H3,(H,41,42)/t35-/m1/s1 | 別名: | 3-SN-PHOSPHATIDYLETHANOLAMINE | 定義日: | 2008-04-28 | 最終更新日: | 2021-03-01 | 識別子(ID): | (2R)-3-{[(S)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-(tetradecanoyloxy)propyl octadecanoate |
|
| 8PG | 表記: | (8S,12S)-15S-HYDROXY-9-OXOPROSTA-10Z,13E-DIEN-1-OIC ACID | 組成式: | C20 H32 O4 | SMILES: | O=C(O)CCCCCCC1C(=O)C=CC1/C=C/C(O)CCCCC | InChi: | InChI=1S/C20H32O4/c1-2-3-6-9-17(21)14-12-16-13-15-19(22)18(16)10-7-4-5-8-11-20(23)24/h12-18,21H,2-11H2,1H3,(H,23,24)/b14-12+/t16-,17-,18-/m0/s1 | 別名: | 8-ISO PROSTAGLANDIN A1 (8-ISO PGA1) | 定義日: | 2006-02-27 | 最終更新日: | 2021-03-01 | 識別子(ID): | (8beta,12alpha,13E,15S)-15-hydroxy-9-oxoprosta-10,13-dien-1-oic acid |
|
| 8PO | 表記: | (2R)-2-(4-hydroxyphenyl)-2-[[(2S)-2-methyl-3-sulfanyl-propanoyl]amino]ethanoic acid | 組成式: | C12 H15 N O4 S | SMILES: | C[CH](CS)C(=O)N[CH](C(O)=O)c1ccc(O)cc1 | InChi: | InChI=1S/C12H15NO4S/c1-7(6-18)11(15)13-10(12(16)17)8-2-4-9(14)5-3-8/h2-5,7,10,14,18H,6H2,1H3,(H,13,15)(H,16,17)/t7-,10-/m1/s1 | 別名: | (R)-2-(4-hydroxyphenyl)-2-((S)-3-mercapto-2-methylpropanamido)acetic acid | 定義日: | 2017-08-24 | 最終更新日: | 2021-03-01 | 公開日: | 2018-01-24 | 識別子(ID): | (2~{R})-2-(4-hydroxyphenyl)-2-[[(2~{S})-2-methyl-3-sulfanyl-propanoyl]amino]ethanoic acid |
|
| 2G7 | 表記: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-1-(isobutylamino)-4-methyl-1-oxopentan-2-yl)phosphonamidic acid | 組成式: | C19 H32 N3 O5 P | SMILES: | O=C(NCC(C)C)C(NP(=O)(O)CNC(=O)OCc1ccccc1)CC(C)C | InChi: | InChI=1S/C19H32N3O5P/c1-14(2)10-17(18(23)20-11-15(3)4)22-28(25,26)13-21-19(24)27-12-16-8-6-5-7-9-16/h5-9,14-15,17H,10-13H2,1-4H3,(H,20,23)(H,21,24)(H2,22,25,26)/t17-/m0/s1 | 別名: | N~2~-[(R)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-N-(2-methylpropyl)-L-leucinamide | 定義日: | 2013-10-11 | 最終更新日: | 2021-03-01 | 公開日: | 2014-04-02 | 識別子(ID): | N~2~-[(R)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-N-(2-methylpropyl)-L-leucinamide |
|
| 2GC | 表記: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-4-methyl-1-oxo-1-(phenethylamino)pentan-2-yl)phosphonamidic acid | 組成式: | C23 H32 N3 O5 P | SMILES: | C(OC(=O)NCP(NC(CC(C)C)C(=O)NCCc1ccccc1)(=O)O)c2ccccc2 | InChi: | InChI=1S/C23H32N3O5P/c1-18(2)15-21(22(27)24-14-13-19-9-5-3-6-10-19)26-32(29,30)17-25-23(28)31-16-20-11-7-4-8-12-20/h3-12,18,21H,13-17H2,1-2H3,(H,24,27)(H,25,28)(H2,26,29,30)/t21-/m0/s1 | 別名: | N~2~-[(R)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-N-(2-phenylethyl)-L-leucinamide | 定義日: | 2013-10-11 | 最終更新日: | 2021-03-01 | 公開日: | 2014-04-02 | 識別子(ID): | N~2~-[(R)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-N-(2-phenylethyl)-L-leucinamide |
|
| 2GF | 表記: | [(2R,5R)-5-(4-amino-5-chloro-2-oxopyrimidin-1(2H)-yl)-3-oxotetrahydrofuran-2-yl]methyl dihydrogen phosphate | 組成式: | C9 H11 Cl N3 O7 P | SMILES: | O=P(O)(O)OCC2OC(N1C(=O)N=C(N)C(Cl)=C1)CC2=O | InChi: | InChI=1S/C9H11ClN3O7P/c10-4-2-13(9(15)12-8(4)11)7-1-5(14)6(20-7)3-19-21(16,17)18/h2,6-7H,1,3H2,(H2,11,12,15)(H2,16,17,18)/t6-,7-/m1/s1 | 別名: | 5-CHLORO DEOXYCYTIDINE-5'-MONOPHOSPHATE | 定義日: | 2013-10-15 | 最終更新日: | 2021-03-01 | 公開日: | 2013-11-06 | 識別子(ID): | [(2R,5R)-5-(4-amino-5-chloro-2-oxopyrimidin-1(2H)-yl)-3-oxotetrahydrofuran-2-yl]methyl dihydrogen phosphate |
|
| 2H0 | 表記: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-1-(isopentylamino)-4-methyl-1-oxopentan-2-yl)phosphonamidic acid | 組成式: | C20 H34 N3 O5 P | SMILES: | O=C(NCCC(C)C)C(NP(=O)(O)CNC(=O)OCc1ccccc1)CC(C)C | InChi: | InChI=1S/C20H34N3O5P/c1-15(2)10-11-21-19(24)18(12-16(3)4)23-29(26,27)14-22-20(25)28-13-17-8-6-5-7-9-17/h5-9,15-16,18H,10-14H2,1-4H3,(H,21,24)(H,22,25)(H2,23,26,27)/t18-/m0/s1 | 別名: | N~2~-[(S)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-N-(3-methylbutyl)-L-leucinamide | 定義日: | 2013-10-17 | 最終更新日: | 2021-03-01 | 公開日: | 2014-04-02 | 識別子(ID): | N~2~-[(S)-({[(benzyloxy)carbonyl]amino}methyl)(hydroxy)phosphoryl]-N-(3-methylbutyl)-L-leucinamide |
|
| 2IW | 表記: | 4-[(3aR,4S,7R,7aS)-1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl]-N-(4-methylquinolin-8-yl)benzamide | 組成式: | C26 H21 N3 O3 | SMILES: | O=C(Nc2c1nccc(c1ccc2)C)c3ccc(cc3)N5C(=O)C6C4C=CC(C4)C6C5=O | InChi: | InChI=1S/C26H21N3O3/c1-14-11-12-27-23-19(14)3-2-4-20(23)28-24(30)15-7-9-18(10-8-15)29-25(31)21-16-5-6-17(13-16)22(21)26(29)32/h2-12,16-17,21-22H,13H2,1H3,(H,28,30)/t16-,17+,21-,22+ | 別名: | IWR-2 | 定義日: | 2012-03-06 | 最終更新日: | 2021-03-01 | 識別子(ID): | 4-[(3aR,4S,7R,7aS)-1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl]-N-(4-methylquinolin-8-yl)benzamide |
|
| K5Y | 表記: | salmeterol | 組成式: | C25 H37 N O4 | SMILES: | c1c(cccc1)CCCCOCCCCCCNCC(O)c2cc(c(cc2)O)CO | InChi: | InChI=1S/C25H37NO4/c27-20-23-18-22(13-14-24(23)28)25(29)19-26-15-7-1-2-8-16-30-17-9-6-12-21-10-4-3-5-11-21/h3-5,10-11,13-14,18,25-29H,1-2,6-9,12,15-17,19-20H2/t25-/m0/s1 | 別名: | 2-(hydroxymethyl)-4-[(1R)-1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl]phenol | 定義日: | 2018-11-01 | 最終更新日: | 2021-03-01 | 公開日: | 2018-11-14 | 識別子(ID): | 2-(hydroxymethyl)-4-[(1R)-1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl]phenol |
|
| 2L3 | 表記: | (2R)-2-methyl-1,4-dioxo-1,2,3,4-tetrahydronaphthalene-2-sulfonic acid | 組成式: | C11 H10 O5 S | SMILES: | O=S(=O)(O)C2(C(=O)c1c(cccc1)C(=O)C2)C | InChi: | InChI=1S/C11H10O5S/c1-11(17(14,15)16)6-9(12)7-4-2-3-5-8(7)10(11)13/h2-5H,6H2,1H3,(H,14,15,16)/t11-/m1/s1 | 別名: | menadione bisulfite | 定義日: | 2013-11-25 | 最終更新日: | 2021-03-01 | 公開日: | 2014-02-19 | 識別子(ID): | (2R)-2-methyl-1,4-dioxo-1,2,3,4-tetrahydronaphthalene-2-sulfonic acid |
|
| 2L4 | 表記: | 1-deoxy-1-({2,6-dioxo-5-[(E)-(2-oxoethylidene)amino]-1,2,3,6-tetrahydropyrimidin-4-yl}amino)-D-ribitol | 組成式: | C11 H16 N4 O7 | SMILES: | O=C1NC(NCC(O)C(O)C(O)CO)=C(N=CC=O)C(=O)N1 | InChi: | InChI=1S/C11H16N4O7/c16-2-1-12-7-9(14-11(22)15-10(7)21)13-3-5(18)8(20)6(19)4-17/h1-2,5-6,8,17-20H,3-4H2,(H3,13,14,15,21,22)/b12-1+/t5-,6+,8-/m0/s1 | 別名: | 5-(2-oxoethylideneamino)-6-D-ribitylaminouracil | 定義日: | 2013-11-25 | 最終更新日: | 2021-03-01 | 公開日: | 2014-04-16 | 識別子(ID): | 1-deoxy-1-({2,6-dioxo-5-[(E)-(2-oxoethylidene)amino]-1,2,3,6-tetrahydropyrimidin-4-yl}amino)-D-ribitol |
|
| 2LB | 表記: | (2S)-2-methyl-1,4-dioxo-1,2,3,4-tetrahydronaphthalene-2-sulfonic acid | 組成式: | C11 H10 O5 S | SMILES: | O=S(=O)(O)C2(C(=O)c1c(cccc1)C(=O)C2)C | InChi: | InChI=1S/C11H10O5S/c1-11(17(14,15)16)6-9(12)7-4-2-3-5-8(7)10(11)13/h2-5H,6H2,1H3,(H,14,15,16)/t11-/m0/s1 | 別名: | menadione bisulfite | 定義日: | 2013-11-26 | 最終更新日: | 2021-03-01 | 公開日: | 2014-02-19 | 識別子(ID): | (2S)-2-methyl-1,4-dioxo-1,2,3,4-tetrahydronaphthalene-2-sulfonic acid |
|
| K6H | 表記: | (2S)-2-chloranyl-2-[(2R)-5-oxidanylidene-2H-furan-2-yl]ethanoic acid | 組成式: | C6 H5 Cl O4 | SMILES: | O=C1OC(C=C1)C(Cl)C(=O)O | InChi: | InChI=1S/C6H5ClO4/c7-5(6(9)10)3-1-2-4(8)11-3/h1-3,5H,(H,9,10)/t3-,5+/m1/s1 | 別名: | 5-CHLOROMUCONOLACTONE | 定義日: | 2013-02-20 | 最終更新日: | 2021-03-01 | 公開日: | 2013-03-06 | 識別子(ID): | (2S)-chloro[(2R)-5-oxo-2,5-dihydrofuran-2-yl]ethanoic acid |
|
| 2LJ | 表記: | 1-deoxy-1-({2,6-dioxo-5-[(E)-propylideneamino]-1,2,3,6-tetrahydropyrimidin-4-yl}amino)-D-ribitol | 組成式: | C12 H20 N4 O6 | SMILES: | C1(=O)NC(NC(=C1N=CCC)NCC(O)C(O)C(O)CO)=O | InChi: | InChI=1S/C12H20N4O6/c1-2-3-13-8-10(15-12(22)16-11(8)21)14-4-6(18)9(20)7(19)5-17/h3,6-7,9,17-20H,2,4-5H2,1H3,(H3,14,15,16,21,22)/b13-3+/t6-,7+,9-/m0/s1 | 別名: | 5-(2-oxopropylideneamino)-6-D-ribitylaminouracil | 定義日: | 2013-11-27 | 最終更新日: | 2021-03-01 | 公開日: | 2014-04-16 | 識別子(ID): | 1-deoxy-1-({2,6-dioxo-5-[(E)-propylideneamino]-1,2,3,6-tetrahydropyrimidin-4-yl}amino)-D-ribitol |
|
| 2M1 | 表記: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(3S)-5-methyl-1-(methylsulfonyl)hexan-3-yl]-L-leucinamide | 組成式: | C28 H47 N3 O6 S | SMILES: | O=S(=O)(C)CCC(NC(=O)C(NC(=O)C(NC(=O)OCc1ccccc1)CC(C)C)CC(C)C)CC(C)C | InChi: | InChI=1S/C28H47N3O6S/c1-19(2)15-23(13-14-38(7,35)36)29-26(32)24(16-20(3)4)30-27(33)25(17-21(5)6)31-28(34)37-18-22-11-9-8-10-12-22/h8-12,19-21,23-25H,13-18H2,1-7H3,(H,29,32)(H,30,33)(H,31,34)/t23-,24+,25+/m1/s1 | 別名: | PHQ-Leu-Leu-Leu-vinylsulfone | 定義日: | 2013-12-02 | 最終更新日: | 2021-03-01 | 公開日: | 2014-02-12 | 識別子(ID): | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(3S)-5-methyl-1-(methylsulfonyl)hexan-3-yl]-L-leucinamide |
|
| K7J | 表記: | N-(3-carboxypropanoyl)-L-alanyl-L-alanyl-N-[(2S,3S)-4-chloro-3-hydroxy-1-phenylbutan-2-yl]-L-prolinamide | 組成式: | C25 H35 Cl N4 O7 | SMILES: | O=C(NC(Cc1ccccc1)C(O)CCl)C2N(C(=O)C(NC(=O)C(NC(=O)CCC(=O)O)C)C)CCC2 | InChi: | InChI=1S/C25H35ClN4O7/c1-15(27-21(32)10-11-22(33)34)23(35)28-16(2)25(37)30-12-6-9-19(30)24(36)29-18(20(31)14-26)13-17-7-4-3-5-8-17/h3-5,7-8,15-16,18-20,31H,6,9-14H2,1-2H3,(H,27,32)(H,28,35)(H,29,36)(H,33,34)/t15-,16-,18-,19-,20+/m0/s1 | 別名: | SUCCINYL-ALA-ALA-PRO-PHE-CHLOROMETHYL KETONE | 定義日: | 2007-11-12 | 最終更新日: | 2021-03-01 | 識別子(ID): | N-(3-carboxypropanoyl)-L-alanyl-L-alanyl-N-[(2S,3S)-4-chloro-3-hydroxy-1-phenylbutan-2-yl]-L-prolinamide |
|
| K85 | 表記: | propan-2-yl 3-{3-[3-methoxy-5-(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl}propanoate | 組成式: | C16 H18 F3 N3 O3 | SMILES: | FC(F)(F)c2cc(c1ncn(n1)CCC(=O)OC(C)C)cc(OC)c2 | InChi: | InChI=1S/C16H18F3N3O3/c1-10(2)25-14(23)4-5-22-9-20-15(21-22)11-6-12(16(17,18)19)8-13(7-11)24-3/h6-10H,4-5H2,1-3H3 | 別名: | KPT-185 | 定義日: | 2012-08-23 | 最終更新日: | 2021-03-01 | 公開日: | 2012-10-12 | 識別子(ID): | propan-2-yl 3-{3-[3-methoxy-5-(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl}propanoate |
|
| 2NC | 表記: | N-{(2S)-2-[(N-acetyl-L-threonyl-L-isoleucyl)amino]hexyl}-L-norleucyl-L-glutaminyl-N~5~-[amino(iminio)methyl]-L-ornithinamide | 組成式: | C35 H68 N11 O8 | SMILES: | O=C(NC(C(=O)NC(CCCC)CNC(C(=O)NC(C(=O)NC(C(=O)N)CCCNC(=[NH2+])N)CCC(=O)N)CCCC)C(C)CC)C(NC(=O)C)C(O)C | InChi: | InChI=1S/C35H67N11O8/c1-7-10-13-23(43-33(53)28(20(4)9-3)46-34(54)29(21(5)47)42-22(6)48)19-41-25(14-11-8-2)31(51)45-26(16-17-27(36)49)32(52)44-24(30(37)50)15-12-18-40-35(38)39/h20-21,23-26,28-29,41,47H,7-19H2,1-6H3,(H2,36,49)(H2,37,50)(H,42,48)(H,43,53)(H,44,52)(H,45,51)(H,46,54)(H4,38,39,40)/p+1/t20-,21+,23-,24-,25-,26-,28-,29-/m0/s1 | 別名: | p2/NC | 定義日: | 2008-03-24 | 最終更新日: | 2021-03-01 | 識別子(ID): | N-{(2S)-2-[(N-acetyl-L-threonyl-L-isoleucyl)amino]hexyl}-L-norleucyl-L-glutaminyl-N~5~-[amino(iminio)methyl]-L-ornithinamide |
|
| 2NV | 表記: | 3,6,9,12,15-pentaoxaoctadecan-17-amine | 組成式: | C13 H29 N O5 | SMILES: | NC(C)COCCOCCOCCOCCOCC | InChi: | InChI=1S/C13H29NO5/c1-3-15-4-5-16-6-7-17-8-9-18-10-11-19-12-13(2)14/h13H,3-12,14H2,1-2H3/t13-/m1/s1 | 別名: | Jeffamine ED-2001 | 定義日: | 2014-04-21 | 最終更新日: | 2021-03-01 | 公開日: | 2014-04-30 | 識別子(ID): | (17R)-3,6,9,12,15-pentaoxaoctadecan-17-amine |
|
| 2OY | 表記: | N-[(2S,3S)-7-amino-1-chloro-2-hydroxyheptan-3-yl]-4-methylbenzenesulfonamide (Bound Form) | 組成式: | C14 H23 Cl N2 O3 S | SMILES: | O=S(=O)(NC(CCCCN)C(O)CCl)c1ccc(cc1)C | InChi: | InChI=1S/C14H23ClN2O3S/c1-11-5-7-12(8-6-11)21(19,20)17-13(14(18)10-15)4-2-3-9-16/h5-8,13-14,17-18H,2-4,9-10,16H2,1H3/t13-,14+/m0/s1 | 別名: | Tosyllysine Chloromethyl Ketone (Bound Form) | 定義日: | 2013-12-19 | 最終更新日: | 2021-03-01 | 公開日: | 2014-04-23 | 識別子(ID): | N-[(2S,3S)-7-amino-1-chloro-2-hydroxyheptan-3-yl]-4-methylbenzenesulfonamide |
|
| 2P0 | 表記: | 1-({[(S)-hydroxy(phosphonooxy)phosphoryl]oxy}acetyl)-L-proline | 組成式: | C7 H13 N O10 P2 | SMILES: | O=C(N1C(C(=O)O)CCC1)COP(=O)(O)OP(=O)(O)O | InChi: | InChI=1S/C7H13NO10P2/c9-6(8-3-1-2-5(8)7(10)11)4-17-20(15,16)18-19(12,13)14/h5H,1-4H2,(H,10,11)(H,15,16)(H2,12,13,14)/t5-/m0/s1 | 別名: | diphosphoglycolylproline | 定義日: | 2011-02-24 | 最終更新日: | 2021-03-01 | 識別子(ID): | 1-({[(S)-hydroxy(phosphonooxy)phosphoryl]oxy}acetyl)-L-proline |
|
| KAH | 表記: | 5-AMINO-4-HYDROXYHEXANOIC ACID | 組成式: | C6 H13 N O3 | SMILES: | O=C(O)CCC(O)C(N)C | InChi: | InChI=1S/C6H13NO3/c1-4(7)5(8)2-3-6(9)10/h4-5,8H,2-3,7H2,1H3,(H,9,10)/t4-,5-/m1/s1 | 別名: | 4-KETO-5-AMINO-HEXANOIC ACID | 定義日: | 2001-07-09 | 最終更新日: | 2021-03-01 | 識別子(ID): | (4R,5R)-5-amino-4-hydroxyhexanoic acid |
|
| KAL | 表記: | Kalimantacin | 組成式: | C30 H48 N2 O7 | SMILES: | C[CH](CC=CC=CCCC(=C)C[CH](C)CC(C)=CC(O)=O)CC(=O)C[CH](O)CNC(=O)[CH](C)[CH](C)OC(N)=O | InChi: | InChI=1S/C30H48N2O7/c1-20(14-22(3)15-23(4)17-28(35)36)12-10-8-7-9-11-13-21(2)16-26(33)18-27(34)19-32-29(37)24(5)25(6)39-30(31)38/h7-9,11,17,21-22,24-25,27,34H,1,10,12-16,18-19H2,2-6H3,(H2,31,38)(H,32,37)(H,35,36)/b8-7-,11-9+,23-17+/t21-,22+,24+,25+,27+/m0/s1 | 別名: | batumin | 定義日: | 2019-01-21 | 最終更新日: | 2021-03-01 | 公開日: | 2020-04-01 | 識別子(ID): | (2~{E},5~{R},10~{Z},12~{E},15~{S},19~{R})-20-[[(2~{R},3~{R})-3-aminocarbonyloxy-2-methyl-butanoyl]amino]-3,5,15-trimethyl-7-methylidene-19-oxidanyl-17-oxidanylidene-icosa-2,10,12-trienoic acid |
|
| KAM | 表記: | N-[7-KETO-8-AMINOPELARGONIC ACID]-[3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL-PYRIDIN-4-YL-METHANE] | 組成式: | C17 H27 N2 O8 P | SMILES: | O=C(O)CCCCCC(=O)C(NCc1c(cnc(c1O)C)COP(=O)(O)O)C | InChi: | InChI=1S/C17H27N2O8P/c1-11(15(20)6-4-3-5-7-16(21)22)19-9-14-13(10-27-28(24,25)26)8-18-12(2)17(14)23/h8,11,19,23H,3-7,9-10H2,1-2H3,(H,21,22)(H2,24,25,26)/t11-/m0/s1 | 別名: | N-PYRIDOXYL-7-KETO-8-AMINOPELARGONIC ACID-5'-MONOPHOSPHATE | 定義日: | 1999-12-08 | 最終更新日: | 2021-03-01 | 識別子(ID): | (8S)-8-[({3-hydroxy-2-methyl-5-[(phosphonooxy)methyl]pyridin-4-yl}methyl)amino]-7-oxononanoic acid |
|